Clinical Trials Logo

Clinical Trial Summary

This is a prospective, non-randomized, single-center, evaluator blinded study of up to 15 subjects undergoing a minimally invasive breast lift procedure utilizing the Renuvion APR System. Subjects will receive treatment with the Renuvion APR System to both breasts.


Clinical Trial Description

This is a prospective, non-randomized, single-center, evaluator blinded study of up to 15 subjects undergoing a minimally invasive breast lift procedure utilizing the Renuvion APR System. Subjects will receive treatment with the Renuvion APR System to both breasts. At baseline, the grade of breast ptosis, breast measurements and pre-surgery photographs will be taken using the site's camera system. Procedure data and adverse events will be captured. Follow-up visits will occur at 30, 90, and 180-days post-procedure. Subjects may also be seen back for follow-up at the investigator's discretion. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05665335
Study type Interventional
Source Apyx Medical
Contact
Status Completed
Phase N/A
Start date November 28, 2022
Completion date April 26, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT00775788 - Autologous Fat Grafting to the Breast N/A
Completed NCT00959374 - Evaluation of Dermal Closure With an Absorbable Barbed Suture as Compared to a Conventional Absorbable Suture N/A
Completed NCT06262724 - Breast Reshaping Following Massive Weight Loss N/A
Withdrawn NCT00774059 - Evaluation of Safety and Performance of the Orbix Breast Lift System N/A